Among American women, breast cancer is the most common cancer, after skin cancer. About 1 in 8 (12 percent) women in the U.S. will develop invasive breast cancer during their lifetime.
For 2017, the American Cancer Society estimates that:
Incidence rates of breast cancer are highest in non-Hispanic white women; however, breast cancer death rates are highest in African American women.
Source: American Cancer Society Breast Cancer Facts & Figures 2017-2018.
Breast cancer is the second leading cause of cancer death in women, surpassed only by lung cancer. Death rates from breast cancer have been declining since about 1989, with larger decreases in women younger than age 50. It is believed that earlier detection through screening and increased awareness, as well as improved treatment, has led to these decreases.
Today, there are more than 3 million breast cancer survivors in the U.S.
Source: Miller KD, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66:271–289.
The ongoing ACCC Metastatic Breast Cancer project is working to expand multidisciplinary team awareness of how to effectively meet the holistic needs of metastatic breast cancer patients, enhance patient-provider communication, and improve the patient-centeredness of care delivery. View project resources.
For this project, U.S.-based cancer programs and practices now have the opportunity to join in a quality improvement study by testing the new “Dandelion Toolkit” designed to support clear communication, empowering both patients and providers. Toolkits provided to participants free of charge.
Learn More & Apply
To support quality improvement projects in breast cancer, the Association of Community Cancer Centers (ACCC) has joined with Pfizer Independent Grants for Learning and Change (IGLC) to issue a Request for Proposals (RFP) with the intent of funding QI initiatives that fully integrate BRCA testing into patient care plans in order to help inform the treatment decision-making process.
ACCC is partnering with AXIS Medical Education in an educational research project to assess the value of a robust, independent, quality-focused educational intervention that aims to improve a community cancer program's quality measures related to management of patients with HER2+ breast cancer (all stages). Two ACCC-member Cancer Programs are participating in the project.